1. Home
  2. SPRY vs ARRY Comparison

SPRY vs ARRY Comparison

Compare SPRY & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • ARRY
  • Stock Information
  • Founded
  • SPRY 2015
  • ARRY 1989
  • Country
  • SPRY United States
  • ARRY United States
  • Employees
  • SPRY N/A
  • ARRY N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • ARRY Semiconductors
  • Sector
  • SPRY Health Care
  • ARRY Technology
  • Exchange
  • SPRY Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • SPRY 1.1B
  • ARRY 1.3B
  • IPO Year
  • SPRY N/A
  • ARRY 2020
  • Fundamental
  • Price
  • SPRY $8.96
  • ARRY $8.66
  • Analyst Decision
  • SPRY Strong Buy
  • ARRY Buy
  • Analyst Count
  • SPRY 4
  • ARRY 19
  • Target Price
  • SPRY $31.25
  • ARRY $9.92
  • AVG Volume (30 Days)
  • SPRY 1.8M
  • ARRY 5.9M
  • Earning Date
  • SPRY 11-11-2025
  • ARRY 11-05-2025
  • Dividend Yield
  • SPRY N/A
  • ARRY N/A
  • EPS Growth
  • SPRY N/A
  • ARRY N/A
  • EPS
  • SPRY N/A
  • ARRY N/A
  • Revenue
  • SPRY $112,339,000.00
  • ARRY $1,171,244,000.00
  • Revenue This Year
  • SPRY N/A
  • ARRY $34.42
  • Revenue Next Year
  • SPRY $193.13
  • ARRY $14.38
  • P/E Ratio
  • SPRY N/A
  • ARRY N/A
  • Revenue Growth
  • SPRY 22367.80
  • ARRY 6.36
  • 52 Week Low
  • SPRY $8.45
  • ARRY $3.76
  • 52 Week High
  • SPRY $18.90
  • ARRY $10.37
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 36.31
  • ARRY 49.04
  • Support Level
  • SPRY $9.08
  • ARRY $8.70
  • Resistance Level
  • SPRY $10.38
  • ARRY $9.54
  • Average True Range (ATR)
  • SPRY 0.51
  • ARRY 0.63
  • MACD
  • SPRY -0.09
  • ARRY -0.08
  • Stochastic Oscillator
  • SPRY 17.43
  • ARRY 22.15

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: